Statement of Changes in Beneficial Ownership (4)
March 05 2020 - 1:23PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
READING CHRISTOPHER J |
2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV
[
USPH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer |
(Last)
(First)
(Middle)
1300 W. SAM HOUSTON PKWY S., SUITE 300 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/3/2020 |
(Street)
HOUSTON, TX 77042
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 3/3/2020 | | A | | 14380 (1) | A | $0.00 | 76438 (2) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | The 14,380 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installment with the 898 shares on April 1, 2020 and thereafter with 898 shares on April 1, July 1, October 1 and January 1 of each year with the final 910 shares lapsing on January 1, 2024. |
(2) | Includes 43,937 shares which restrictions lapse as to 4,462 shares on each of April 1, July 1 and October 1, 2020; 4,476 shares on January 1, 2021; 3,441 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 2,176 shares on each of April 1, July 1 and October 1, 2022; 2,179 shares on January 1, 2023; 898 shares on each of April 1, July 1 and October 1 2023 and 910 shares on January 1, 2024. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
READING CHRISTOPHER J 1300 W. SAM HOUSTON PKWY S. SUITE 300 HOUSTON, TX 77042 | X |
| Chief Executive Officer |
|
Signatures
|
/s/ Christopher J Reading | | 3/5/2020 |
**Signature of Reporting Person | Date |
US Physical Therapy (NYSE:USPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
US Physical Therapy (NYSE:USPH)
Historical Stock Chart
From Sep 2023 to Sep 2024